期刊
TRENDS IN CANCER
卷 7, 期 8, 页码 682-699出版社
CELL PRESS
DOI: 10.1016/j.trecan.2021.02.004
关键词
-
类别
资金
- European Research Council (ERC) [771486MetaRegulation]
- Fonds Wetenschappelijk Onderzoek (FWO) research projects
- KU Leuven Methusalem Co-Funding
- Fonds Baillet Latour
- Associazione Italiana Ricerca sul Cancro (AIRC) [19515]
- Associazione Italiana per la Ricerca sul Cancro (AIRC) [24132]
- University of Florence
This study emphasizes the important role of amino acid metabolic reprogramming in cancer therapy, with amino acids playing a crucial role in acquiring resistance to anticancer drugs, especially in terms of the resistance of cancer stem cells.
Overcoming anticancer drug resistance is a major challenge in cancer therapy, requiring innovative strategies that consider the extensive tumor heterogeneity and adaptability. We provide recent evidence highlighting the key role of amino acid (AA) metabolic reprogramming in cancer cells and the supportive microenvironment in driving resistance to anticancer therapies. AAs sustain the acquisition of anticancer resistance by providing essential building blocks for biosynthetic pathways and for maintaining a balanced redox status, and modulating the epigenetic profile of both malignant and non-malignant cells. In addition, AAs support the reduced intrinsic susceptibility of cancer stem cells to antineoplastic therapies. These findings shed new light on the possibility of targeting non-responding tumors by modulating AA availability through pharmacological or dietary interventions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据